Aptevo Therapeutics Inc. — All Filings
692 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12B
10-12B/A
10-K
10-K/A
10-Q
10-Q/A
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DEFR14A
DFAN14A
DRS
EFFECT
PRE 14A
PREC14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-22-034876 | Jun 7, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-034873 | Jun 7, 2022 | — |
| S-8 | S-8 | 0001564590-22-022706 | Jun 7, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-034879 | Jun 7, 2022 | — |
| 8-K | 8-K | 0001564590-22-022694 | Jun 7, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033920 | Jun 3, 2022 | Jun 1, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033936 | Jun 3, 2022 | Jun 1, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033933 | Jun 3, 2022 | Jun 1, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033930 | Jun 3, 2022 | Jun 1, 2022 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033928 | Jun 3, 2022 | Aug 3, 2016 |
| 4 | FORM 4 SUBMISSION | 0001209191-22-033924 | Jun 3, 2022 | Jun 1, 2022 |
| 8-K | 8-K | 0001564590-22-021764 | May 31, 2022 | May 26, 2022 |
| 8-K | 8-K | 0001564590-22-019680 | May 12, 2022 | — |
| 10-Q | 10-Q | 0001564590-22-019685 | May 12, 2022 | Mar 31, 2022 |
| DEF 14A | DEF 14A | 0001564590-22-015884 | Apr 27, 2022 | Jun 7, 2022 |
| 8-K | 8-K | 0001564590-22-013856 | Apr 7, 2022 | Apr 1, 2022 |
| 8-K/A | 8-K/A | 0001564590-22-012331 | Mar 30, 2022 | Mar 29, 2022 |
| 424B5 | 424B5 | 0001564590-22-012065 | Mar 29, 2022 | — |
| 8-K | 8-K | 0001564590-22-012068 | Mar 29, 2022 | — |
| 424B5 | 424B5 | 0001564590-22-011578 | Mar 24, 2022 | — |
| 10-K | 10-K | 0001564590-22-011575 | Mar 24, 2022 | Dec 31, 2021 |
| 8-K | 8-K | 0001564590-22-011574 | Mar 24, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-016448 | Mar 4, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-016457 | Mar 4, 2022 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-22-016453 | Mar 4, 2022 | — |
| 424B5 | 424B5 | 0001564590-22-005705 | Feb 18, 2022 | — |
| 8-K | 8-K | 0001564590-22-005709 | Feb 18, 2022 | — |
| 8-K | 8-K | 0001564590-22-005567 | Feb 17, 2022 | Feb 16, 2022 |
| SC 13G/A | — | 0001037389-22-000012 | Feb 10, 2022 | — |
| 8-K | 8-K | 0001564590-22-004304 | Feb 9, 2022 | — |
| 4 | — | 0001019056-22-000114 | Feb 1, 2022 | Jan 29, 2022 |
| 4 | — | 0001019056-22-000112 | Feb 1, 2022 | Jan 29, 2022 |
| 8-K | APVO-2022-01-21 8K | 0001564590-22-001848 | Jan 21, 2022 | — |
| 4 | — | 0001019056-21-000634 | Dec 7, 2021 | Dec 3, 2021 |
| SC 13D/A | AMENDMENT NO. 5 | 0001214659-21-012287 | Nov 26, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-066910 | Nov 26, 2021 | Nov 23, 2021 |
| 8-K | APVO-2021-11-23 8K | 0001564590-21-057958 | Nov 23, 2021 | — |
| SC 13D/A | AMENDMENT NO. 4 | 0001214659-21-012163 | Nov 22, 2021 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-21-066146 | Nov 22, 2021 | Nov 18, 2021 |
| 8-K | 8-K | 0001564590-21-056501 | Nov 12, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-056494 | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | 8-K | 0001564590-21-054903 | Nov 5, 2021 | — |
| 8-K | 8-K | 0001564590-21-046031 | Aug 27, 2021 | Aug 25, 2021 |
| EFFECT | — | 9999999995-21-003255 | Aug 19, 2021 | — |
| CORRESP | — | 0001564590-21-044951 | Aug 17, 2021 | — |
| UPLOAD | — | 0000000000-21-010105 | Aug 17, 2021 | — |
| 8-K | 8-K | 0001564590-21-044788 | Aug 17, 2021 | — |
| S-3 | S-3 | 0001564590-21-044029 | Aug 12, 2021 | — |
| 8-K | 8-K | 0001564590-21-043975 | Aug 12, 2021 | — |
| 10-Q | 10-Q | 0001564590-21-043955 | Aug 12, 2021 | Jun 30, 2021 |